通过抑制PI3K/AKT/mTOR通路,抑制RASD1可以改善MASLD的进展
Guifang Zeng1, Xialei Liu2, Zhouying Zheng2
1Department of Hepatobiliary Surgery, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong, 519000, People's Republic of China. zenggf6@mail2.sysu.edu.cn.
Lipids in health and disease
|December 28, 2024
概括
与RAS相关的德克萨米他诱导的1 (RASD1) 在代谢功能障碍相关的脂肪性肝病 (MASLD) 中被上调. 减少RASD1通过抑制新型脂质生成来减轻脂质沉积,这表明RASD1是MASLD的潜在治疗标.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 分子生物学分子生物学
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 缺乏有效的治疗方法.
- 与Ras相关的甲诱导的1 (RASD1) 在MASLD病变发生过程中的作用尚不清楚.
研究的目的:
- 研究RASD1在MASLD中的作用.
- 阐明RASD1影响MASLD的潜在机制.
主要方法:
- 在MASLD模型中验证了RASD1表达.
- 研究了肝细胞和具有改变RASD1水平 (过度表达/敲击) 的小鼠中的脂质代谢.
主要成果:
- 在MASLD中,RASD1表达升高.
- RASD1敲击降低了脂质沉积和新的脂质生成基因表达.
- 过度表达RASD1具有相反的效果,表明它通过PI3K/AKT/mTOR通路在脂质代谢调节中的作用.
结论:
- 通过促进脂质生成,RASD1在MASLD中发挥着重要作用.
- 拉斯德1通过PI3K/AKT/mTOR信号通路调节脂质新陈代谢.
- RASD1代表了对MASLD治疗的潜在治疗标.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
The JAK-STAT Signaling Pathway
8.3K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.3K
MAPK Signaling Cascades
4.9K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
4.9K
Abnormal Proliferation
4.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.3K
The Ras Gene
6.0K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.0K


